This episode features Professor Thomas Seyfried, who is an expert in cancer treatment and prevention. Professor Seyfried specializes in understanding the root cause of cancer, how cancer grows, and the use of nutrition and lifestyle to starve cancer cells.
Professor Seyfried will discuss a new way to treat cancer using metabolic therapy, which is a combination of glucose and glutamine targeted therapies, along with a high-fat ketogenic diet.
Professor Seyfried will explain why cancer is not a genetic disease and how the standard of care destroys all cells in the body, leaving patients sick and frail after therapy. Professor Seyfried will also share real success stories, including Pablo Kelly, who was diagnosed with a glioblastoma, given 9 months to live, and survived almost 8 years with metabolic therapy. This episode is important for understanding how to actively treat cancer with nutrition, metabolic therapy, and mitochondria science, and how to prevent cancer through lifestyle changes.
Journal Articles
- Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
- The Warburg Effect: How Does it Benefit Cancer Cells? (Study)
- Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial (Study)
- High-fat diet made Inuits healthier but shorter thanks to gene mutations (Article)
- Cancer as a mitochondrial metabolic disease (Study)
Books
Other Resources
- Find A Carnivore/ Keto Doctor
- Carnivore Macro Calculator
- GoCarnivore Sugar Calculator
- Buy KetoMojo (Ketone Meter)
About Professor Thomas Seyfried
Our research program focuses on mechanisms by which metabolic therapy manages chronic diseases such as epilepsy, neurodegenerative lipid storage diseases, and cancer. The metabolic therapies include caloric restriction, fasting, and ketogenic diets.
Our approach is based on the idea that compensatory metabolic pathways are capable of modifying the pathogenesis of complex diseases. Global shifts in metabolic environment can neutralize molecular pathology. In the case of cancer, these therapies target and kill tumor cells while enhancing the physiological health of normal cells.
The neurochemical and genetic mechanisms of these phenomena are under investigation in novel animal models and include the processes of inflammation, cellular physiology, angiogenesis, and lipid biochemistry.
